Valuable research linked with inhaled steroids

Inhaled corticosteroids are preparations that are applied in case of asthma by children and adults. Individuals that experience mild, moderate and severe asthma take these preparations every day. These preparations prevent inflammation of the airways. Health care providers supervise persons with this disease, adjusting dosage schedule each 6 weeks.
Unfortunately, inhaled corticosteroids, like other preparations, may cause unwanted consequences. Regular administration of these medications is connected with several risks. Is there any way for individuals with asthma to prevent these problems?
A recent research has demonstrated that doctors should not recommend taking these products daily to individuals with mild-to-moderate asthma. This study turned out to be very valuable. It is likely to alter guidelines linked with treatment of asthma.
The study was conducted by doctors of the Texas Medical Brach in Galveston. The physician William Calhoun and his colleagues enrolled 340 persons with asthma in the research. Certain individuals were given inhaled corticosteroids daily; others applied these medicines, when symptoms of asthma attacks appeared. Bronchial reactivity and functions of lungs were measured by the doctors during nine months. The results of the study manifested that there was not any significant difference between these two groups.
According to the specialists, if inhaled corticosteroids are used, when symptoms occur, exacerbation can be prevented. Moreover, these products have prolonged action. It means that positive effects are felt even several days after usage. The specialists suppose that these medications may be taken by individuals with mild-to-moderate asthma only when symptoms appear.
Why is this research valuable? According to certain sources, 25 million Americans suffer from asthma. Undoubtedly, they must be treated. This piece of news must be valuable for them. Moreover, if inhaled corticosteroids are administered prolonged period of time, they may lead to severe negative reactions, such as hormonal imbalance, cataract, etc. Thus, if persons with mild-to-moderate asthma don’t use these products each day, they are more unlikely to get these negative results.
Undoubtedly, it is early to change recommendations connected with treatment of asthma. But this research may serve as a basis for further studies which may lead to several changes.